Collegium Pharma (COLL) Tops Q3 EPS by 29c

Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
• Adobe Systems (ADBE) Tops Q3 EPS by 6c, Offers Guidance